Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis.
暂无分享,去创建一个
Mimi C. Yu | M. Yu | C. Schmutte | J. Felix | L. Dubeau | K. Cofer | K. Cofer | P. Cheng
[1] J. Felix,et al. Potential role of the inactivated X chromosome in ovarian epithelial tumor development. , 1996, Journal of the National Cancer Institute.
[2] R. Beart,et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.
[3] A. Balmain. Cancer: Exploring the bowels of DNA methylation , 1995, Current Biology.
[4] W. Benedict,et al. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. , 1995, Journal of the National Cancer Institute.
[5] M. Rudnicki,et al. MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. , 1994, Development.
[6] J. Herman,et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Coetzee,et al. Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation , 1994, Molecular and cellular biology.
[8] J. Goodman,et al. Alterations in the methylation status and expression of the raf oncogene in phenobarbital‐induced and spontaneous B6C3F1 mouse liver tumors , 1994, Molecular carcinogenesis.
[9] Rudolf Jaenisch,et al. Role for DNA methylation in genomic imprinting , 1993, Nature.
[10] S. Baylin,et al. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. , 1993, Cancer research.
[11] R. Kurman,et al. The behavior of serous tumors of low malignant potential: are they ever malignant? , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[12] S. Baylin,et al. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. , 1993, Cancer research.
[13] John Calvin Reed,et al. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. , 1993, Blood.
[14] Adrian Bird,et al. The essentials of DNA methylation , 1992, Cell.
[15] Rudolf Jaenisch,et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.
[16] B. Oostra,et al. Trinucleotide repeat polymorphism in the androgen receptor gene (AR). , 1992, Nucleic acids research.
[17] K. Bock,et al. Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. , 1991, Biochemical pharmacology.
[18] S. Baylin,et al. Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. , 1991, Blood.
[19] T. Dryja,et al. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.
[20] H. Radzun,et al. Increased methylation of the c-fms protooncogene in acute myelomonocytic leukemias. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.
[21] A. Bird,et al. High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines , 1990, Cell.
[22] S. Tapscott,et al. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[24] L. Dubeau,et al. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. , 1990, Oncogene.
[25] L. Alhonen,et al. Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. , 1988, Blood.
[26] L. Poirier,et al. c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. , 1988, Carcinogenesis.
[27] A. Feinberg,et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.
[28] H. Cedar,et al. Regulation of mouse satellite DNA replication time. , 1988, The EMBO journal.
[29] A. Bird. CpG-rich islands and the function of DNA methylation , 1986, Nature.
[30] H. Cedar,et al. Effect of regional DNA methylation on gene expression. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Feinberg,et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. , 1985, Science.
[32] A. Feinberg,et al. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. , 1985, Science.
[33] M. Ehrlich,et al. Quantitative reversed-phase high-performance liquid chromatography of major and modified nucleosides in DNA. , 1984, Journal of chromatography.
[34] M. Ehrlich,et al. The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.
[35] A. Feinberg,et al. Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.
[36] M. Ehrlich,et al. 5-Methylcytosine in eukaryotic DNA. , 1981, Science.
[37] T. Mohandas,et al. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. , 1981, Science.